Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval…
Industry leaders share their expectations from the upcoming Union budget 2025-26. Increased allocation for R&D and…
Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends
Industry experts highlight the evolving dynamics, regulatory needs, and personalised solutions driving the nutra market ahead of…
GLP-1R gold rush: Emerging biotechs can challenge market leaders, says GlobalData
While mega-cap companies dominate the GLP-1R market and are expected to maintain their stronghold in 2030, three smaller biotechs…
Eli Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program
TX-478 could potentially address 30-40 per cent of people with hormone-positive breast cancer, building on Lilly's advancements…
Global Alzheimer’s disease market to reach $19.3 bn in 8MM by 2033
GlobalData’s latest report reveals that, by 2033, DMTs are expected to dominate the global AD market, contributing 73.5 per cent…
Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate…
Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets (RLD Balcoltra) had an estimated annual sale of…
AI is set to improve R&D productivity and lower costs
GlobalData’s latest report reveals that although opinions varied, the respondents agreed that AI has the capacity to both:…
Aragen secures $100 mn investment from Quadria Capital
The investment will result in Quadria acquiring a minority stake in Aragen, at an approximate valuation of $ 1.4 billion,…
Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M
In a letter to the Union Health Ministry, Small & Medium Pharma Manufacturers Association stated that pharma MSMEs are not…